Creative Capital Management Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Creative Capital Management Investments’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$632	Buy	+2	New	+$471	﹤0.01%	1221

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Creative Capital Management Investments's LGND Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 2 shares worth $632. The stake represents ﹤0.01% of the portfolio and ranks #1221 among its holdings.

417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Creative Capital Management Investments held 2 shares of Ligand Pharmaceuticals worth $632 as of Q2 2026.
Ligand Pharmaceuticals was a new Creative Capital Management Investments position in Q2 2026.
Ligand Pharmaceuticals made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1221 holding.
417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.